PIK3CA and glioblastoma: The literature reports that in up to 80% of GBM cases, one or more abnormalities of the PI3K-related pathway have been observed [52], and PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α) mutations are found in approximately 15% of GBM cases [53].